Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz to increase production volume by 7%

12/6/23 KMAZ

Magnit opened the first mini-markets Magnit near

12/6/23 MGNT

SPB Exchange made it possible to exchange frozen assets

12/6/23 SPBE

Yandex.Music launches donations for artists

12/6/23 YNDX

M.Video has started rebranding

12/6/23 MVID

Alrosa is studying the possibility of issuing DFA for diamonds

12/6/23 ALRS

Magnet has chosen PT Application Firewall

12/5/23 POSI

Shareholders of LUKOIL approved dividends for 9 months 2023

12/5/23 LKOH

Rusagro completes modernization of the Balakovo site

12/5/23 RAGR

Fesco expands presence in Southeast Asia

12/5/23 FESH